Abstract
Allergic symptoms usually disturb daily activity of affected subjects. Anti-allergic drug is a specific group of drug designed for allergic symptoms. There are many anti-allergic drugs in use. In addition to oral anti-allergic drugs, there are also non oral anti-allergic drugs. Those forms of anti-allergic drugs are developed expecting for the rapid pharmacological reaction. In this article, the author will briefly review on the patents on non oral anti-allergic drug.
Keywords: Non-oral, anti-allergic drug, patent
Recent Patents on Inflammation & Allergy Drug Discovery
Title: Patenting on Non Oral Anti-Allergic Drug
Volume: 2 Issue: 3
Author(s): Viroj Wiwanitkit
Affiliation:
Keywords: Non-oral, anti-allergic drug, patent
Abstract: Allergic symptoms usually disturb daily activity of affected subjects. Anti-allergic drug is a specific group of drug designed for allergic symptoms. There are many anti-allergic drugs in use. In addition to oral anti-allergic drugs, there are also non oral anti-allergic drugs. Those forms of anti-allergic drugs are developed expecting for the rapid pharmacological reaction. In this article, the author will briefly review on the patents on non oral anti-allergic drug.
Export Options
About this article
Cite this article as:
Wiwanitkit Viroj, Patenting on Non Oral Anti-Allergic Drug, Recent Patents on Inflammation & Allergy Drug Discovery 2008; 2 (3) . https://dx.doi.org/10.2174/187221308786241947
DOI https://dx.doi.org/10.2174/187221308786241947 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
The Assessment of Interleukin-18 on the Risk of Coronary Heart Disease
Medicinal Chemistry HTLV-1 Associated Neurological Disorders
Current Topics in Medicinal Chemistry Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis
Current Drug Targets Aerosol Delivery Devices for the Treatment of Adult Patients in Acute and Critical Care
Current Pharmaceutical Biotechnology Neuroprotective Mechanisms as Treatment Strategy in Alzheimers disease
Current Medicinal Chemistry - Central Nervous System Agents Mucoadhesive Low Molecular Chitosan Complexes to Protect rHuKGF from Proteolysis: <i>In-vitro</i> Characterization and FHs 74 Int Cell Proliferation Studies
Current Pharmaceutical Biotechnology Amyloidosis and Auto-Inflammatory Syndromes
Current Drug Targets - Inflammation & Allergy Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways
Current Pharmaceutical Design Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia
Current Drug Targets Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Current Medicinal Chemistry - Anti-Cancer Agents Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients
Current Drug Safety Hepatic Disposition of Electrophilic Acyl Glucuronide Conjugates
Current Drug Metabolism Nucleic-Acid Delivery Using Lipid Nanocapsules
Current Pharmaceutical Biotechnology Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors
Current Drug Targets Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
Current Pharmaceutical Design The Role of Heme Oxygenase-1 in T Cell-Mediated Immunity: The All Encompassing Enzyme
Current Pharmaceutical Design Genetic Polymorphism in Allergic Rhinitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Epigenetic Signals on Plant Adaptation: a Biotic Stress Perspective
Current Protein & Peptide Science The Role of Innate Immune System Receptors in Epilepsy Research
CNS & Neurological Disorders - Drug Targets